Sahlgrenska Center for Cancer Research
Translational cancer research with the patient in focus
Here at Sahlgrenska Center for Cancer Research (SCCR) we focus our research with the patient in mind. This is so that the cancer patient could receive a better care in the future than in today’s society. Through a close collaboration with the Sahlgrenska University Hospital, we at the centre are trying to find new methods and treatments, which later can be tested and applied directly within the cancer care.
Our research groups work widely
Today our 27 research groups work in a wide spectrum of cancer related research questions, but they all have translational cancer research as a common denominator. Example of areas which are studied are brain cancers, lung cancer, breast cancer, melanoma, radiotherapy, prostate cancer and leukaemia. Other research areas at the centre are also epigenetics, ovarian and cervical cancer, sarcoma, neuroendocrine and thyroid cancers, pancreatic cancer and salivary gland tumors.
The research is in some cases used for developing diagnostic and prognostic tools, which in the longer term can improve the cancer care and ensure that the right treatments are being used.
Overbridging post graduate studies
Through the Cancer Research South (CARES) School we at Sahlgrenska Center for Cancer Research also provide courses within cancer research. As for our work, these courses are overbridging research and clinical work as well. CARES is a graduate research school which offers courses to PhD Students at University of Gothenburg and Lund University, which have both been part of the previous strategic program BioCARE.
Latest news
-
Health and medicineSEK 11 million for research on unique cancertreatment
-
Health and medicineEffective treatment in rare but deadly form ofcancer
-
Health and medicineBest Scientific Paper on FundamentalResearch
-
Health and medicineGroundbreaking research on individually tailored precision medicine for treating lungcancer
-
Health and medicineProtective T cells remain 20 months afterCOVID-19
-
Health and medicineErik Elias receives The Håkan AhlmanAward
-
Health and medicinePekka Jaako received funding from The Swedish Childhood CancerFund
-
Health and medicineProstate cancer medicine not a cure forCOVID-19
-
Health and medicineA total of SEK 31,2 million from the Swedish CancerSociety
-
Health and medicineMultiple tumors without kinship occur simultaneously in the smallintestine
Latest SCCR publications
- Increased MYB alternative promoter usage is associated with relapse in acute ly… (External link)
- Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve p… (External link)
- ASO Visual Abstract: Prognostic Significance of Sentinel Lymph Node Status in T… (External link)
- HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-prev… (External link)
- Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanoma… (External link)
- Comprehensive molecular characterization of adenoid cystic carcinoma reveals tu… (External link)
- NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the r… (External link)
- SCC publications (before name change) (External link)
